Clinical Trials Sponsored by BioMarin Pharmaceutical

Total 19555 results

Jacobus Pharmaceutical

Completed

Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome (DAPPER)

Lambert-Eaton Myasthenic Syndrome | Eaton-Lambert Myasthenic Syndrome

United States
Zeria Pharmaceutical

Completed

To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis

Esophagitis, Reflux

Japan
Zeria Pharmaceutical

Completed

Z-360 Plus GEM in Subjects With Metastatic Pancreatic Adenocarcinoma (ZIPANG)

Metastatic Pancreatic Adenocarcinoma

Japan, Korea, Republic of, Taiwan
JW Pharmaceutical

Completed

Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients

Hyperuricemia | Gout

Korea, Republic of
Bukwang Pharmaceutical

Terminated

Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV

Hepatitis B

Korea, Republic of
Bukwang Pharmaceutical

Terminated

Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201

Hepatitis B

Korea, Republic of
Zeria Pharmaceutical

Completed

To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects

Healthy

Japan
Chugai Pharmaceutical

Completed

Non-drug Study to Assess the Suitability of Assessment Scales in Japanese Individuals With Down Syndrome Aged 6-30

Down Syndrome

Japan
Chugai Pharmaceutical

Terminated

A Single Ascending Dose Study of PCO371 in Healthy Volunteers

Healthy

United States
Zeria Pharmaceutical

Completed

To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia

Functional Dyspepsia

Belgium
Bukwang Pharmaceutical

Completed

Comparative Efficacy and Safety of Fenoverine (FEN-401)

Irritable Bowel Syndrome

Korea, Republic of
Bukwang Pharmaceutical

Completed

An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B

Chronic Hepatitis B

Korea, Republic of
JW Pharmaceutical

Completed

South Korean Pitavastatin Heart Failure Study (SAPHIRE)

Chronic Heart Failure

Korea, Republic of
Bukwang Pharmaceutical

Completed

Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy

Hepatitis C

Korea, Republic of
Kaken Pharmaceutical

Completed

A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)

Periodontitis

Japan
Zeria Pharmaceutical

Completed

Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets

Primary Hypophosphatemic Rickets

Japan
Chugai Pharmaceutical

Completed

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP

Rheumatoid Arthritis
JW Pharmaceutical

Completed

Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects

Hypertension | Hyperlipidemia

Korea, Republic of
Chugai Pharmaceutical

Completed

Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis

Primary Osteoporosis

Japan
Bukwang Pharmaceutical

Completed

Long-term Study With Clevudine

Chronic Hepatitis B

Korea, Republic of
Kaken Pharmaceutical

Completed

Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin)

Periodontitis | Alveolar Bone Loss | Periodontal Attachment Loss

Japan
JW Pharmaceutical

Completed

Efficacy and Safety Study of Iron Sucrose and Oral Iron Acetyl-transferrin Hydroglycerin

Iron Deficiency Anemia

Korea, Republic of
JW Pharmaceutical

Completed

Glufast On Insulin Glargine Trial in Type 2 DM (GLORIA)

Diabetes Mellitus, Type 2

Korea, Republic of
JW Pharmaceutical

Completed

Livalo Acute Myocardial Infarction Study (LAMIS)

Acute Myocardial Infarction

Korea, Republic of
Bukwang Pharmaceutical

Completed

A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects

Healthy Adult Male

Korea, Republic of
JW Pharmaceutical

Completed

Therapeutic Exploratory Study of CWP-0403

Type 2 Diabetes Mellitus

Korea, Republic of
JW Pharmaceutical

Completed

Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Korea, Republic of
Chugai Pharmaceutical

Completed

Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients

Anemia

Japan
Chugai Pharmaceutical

Completed

Correction Study of R744 in Renal Anemia Patients on Hemodialysis

Hemodialysis Patients

Japan
Chugai Pharmaceutical

Completed

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Chemotherapy Induced Anemia
Chugai Pharmaceutical

Completed

Clinical Study of R744 to Peritoneal Dialysis Patients

Peritoneal Dialysis Patients

Japan
Chugai Pharmaceutical

Completed

Clinical Study of R744 to Predialysis Patients

Anemia in Pre-Dialysis Patients

Japan
Chugai Pharmaceutical

Completed

A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C

Chronic Hepatitis C
Chugai Pharmaceutical

Completed

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Chemotherapy Induced Anemia
Chugai Pharmaceutical

Completed

Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)

Rheumatoid Arthritis
Chugai Pharmaceutical

Completed

Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study)

Hemodialysis Patients

Japan
Zeria Pharmaceutical

Completed

To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia

Functional Dyspepsia

Japan
Chugai Pharmaceutical

Completed

Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta)

Predialysis Patients

Japan
Chugai Pharmaceutical

Completed

Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment

Rheumatoid Arthritis
Jacobus Pharmaceutical

Terminated

High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease

Crohn's Disease

United States, Israel
Kaken Pharmaceutical

Completed

Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2

Periodontitis
Kissei Pharmaceutical Co., Ltd.
Maruishi Pharmaceutical

Completed

A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

Uremic Pruritus

Japan
Xintian Pharmaceutical

Not yet recruiting

Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS

Chronic Prostatitis
JW Pharmaceutical

Recruiting

A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients (EPIC)

Gout

Korea, Republic of
JW Pharmaceutical

Recruiting

To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Korea, Republic of
JW Pharmaceutical

Recruiting

To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DM

Type 2 Diabetes Mellitus

Korea, Republic of
Chugai Pharmaceutical

Recruiting

Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients

Celiac Disease

United States, Australia
Kaken Pharmaceutical

Active, not recruiting

A Study to Determine the Effect of KP-001 on Metformin and Midazolam Pharmacokinetics and the Effect of Clarithromycin on KP-001 Pharmacokinetics in Healthy Adult Participants

Healthy Adults

United States
JW Pharmaceutical

Completed

To Evaluate the PK, PD, Safety and Drug Tolerance of JW0302 in Healthy Volunteers

Healthy

Korea, Republic of
JW Pharmaceutical

Completed

To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension

Hypertension | Dyslipidemia

Korea, Republic of

3

Subscribe